Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Buys Essure Contraceptive-Maker Conceptus For $1.1 Billion

This article was originally published in The Gray Sheet

Executive Summary

The acquisition will add a popular nonsurgical, permanent birth control device to Bayer’s line of contraceptive pharmaceuticals and women’s health products.


Related Content

People Briefs
FDA Investigating Attorney, Physician Beefs With Bayer’s Essure PMA
Expect Bayer To Get Heat At FDA Advisory Panel Over Essure Adverse Events, Doc Training
Thoratec Goes Back To The Future With CEO Appointment
People Briefs: Elekta, Zeltiq And Nonin Make Appointments; Gilfillan Goes To CHE Trinity Health
Device/Diagnostics Quarterly Deal Statistics, Q2 2013
People Briefs: Encision, Solta, Chembio, Accuray, Devon and FDA
Emerging Players In Contraceptives Could Reshape A Mature Market
Promotion Pact Broadens Conceptus’ Market For Birth-Control Device


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts